tesamorelin
How to Spot Duplicate Tesamorelin Listings Across Sites
Learn how to spot duplicate tesamorelin listings across different supplier websites, from reused COA images to copied product photography and text.
Medically reviewed by Catherine Dumont, MD, physician and clinical researcher — Last reviewed
Catherine Dumont, MD is a physician with clinical and research training in endocrinology and growth hormone therapeutics, with post-graduate research in GHRH analog applications and growth hormone axis disorders.
Spotting duplicate tesamorelin listings across different supplier websites comes down to checking whether a page’s photography, certificate of analysis, and product copy actually belong to that seller, or were lifted wholesale from somewhere else. In a market with many small storefronts and few manufacturers, the same underlying inventory often gets relisted by several sites under different branding. That is not automatically a problem, but a reader who cannot tell which listings are independently documented and which are copies of a copy has no way to judge whether any one page reflects the product actually being shipped.
Why the Same Listing Shows Up on Multiple Sites
Peptide research compounds move through a small number of manufacturers and repackagers before reaching a retail storefront. A single supplier’s stock can end up listed under several domain names, sometimes run by the same operator and sometimes by unrelated resellers buying from a shared source. Neither arrangement is inherently deceptive. The issue is when a listing presents itself as an independent, verified source while its photos, COA, and description are identical to a page on another domain — because that similarity means the second listing has not actually verified anything on its own. It has copied the first page’s claims along with its images.
Reused Product Photography
The most visible tell is a product photo that appears, pixel for pixel, on more than one supplier’s site. Vial photography with a distinctive background, lighting setup, or prop arrangement is easy to compare side by side. If two listings show the exact same vial at the exact same angle with the same shadow pattern, one of them did not photograph its own stock — both are using an image pulled from a manufacturer’s marketing kit or from each other. A reverse image search on a listing’s product photo is a fast way to check this: paste the image into a search engine’s image-search tool and see how many other storefronts the same file turns up on. A photo appearing on five unrelated domains is a sign that none of those five pages is showing the buyer their actual inventory.
Certificates of Analysis Copied Across Storefronts
A certificate of analysis is supposed to document a specific tested batch. When the same COA image, right down to the lot number and testing date, shows up attached to listings on different domains, only one of two things is happening: either those sites are drawing from the exact same batch and disclosing that honestly, or one site has copied another’s documentation without having tested anything itself. The first case is legitimate and should be stated plainly on the page — a shared source is not a red flag by itself. The second case is not, and it is common enough to check for directly.
The way to check is to look at the lot number and test date printed on the COA and search for that exact string, or upload the COA image the same way as the product photo. If the identical document appears on a storefront selling a different vial size, a different price tier, or a compound described with different terminology, the document is not describing what that particular page is selling.
Matching Text and Matching Errors
Product descriptions get copied more often than sellers admit, and the giveaway is usually a shared phrasing quirk rather than shared vocabulary. Every listing in a niche uses similar terms — “research use only,” “third-party tested,” “cold-chain shipped” — so overlapping word choice alone proves little. What is worth noticing is an unusual sentence structure, an odd unit format, or a typo that shows up verbatim on more than one site. A distinctive run-on sentence or a misspelled amino acid name copied character-for-character across two supposedly unrelated storefronts is a much stronger signal than two sites both using the word “purity.”
Price Structures That Mirror Each Other While Vial Claims Don’t
Duplicate listings sometimes carry the same underlying batch identity — same COA, same lot number — while displaying different vial-mass claims or price points, which is where the numbers stop lining up. If a batch’s assayed mass is fixed, the price per milligram across listings claiming to sell from that batch should track a consistent range even if sticker prices differ for volume or shipping reasons.
| Listing | Claimed Vial Mass | Listed Price | Price per mg | Same COA Lot? |
|---|---|---|---|---|
| Site A | 10 mg | $120 | $12.00 | Yes |
| Site B | 10 mg | $150 | $15.00 | Yes |
| Site C | 10 mg | $118 | $11.80 | No — different lot |
Price per milligram is the listed price divided by the claimed vial mass. For Site A, $120 divided by 10 mg works out to $12.00 per mg. For Site B, $150 divided by 10 mg works out to $15.00 per mg. Both sites cite the same COA lot number for a batch that, by definition, has one assayed mass — so a 25% price gap between them isn’t a documentation problem by itself, but it does mean at least one of the two pages is marking up a copied certificate rather than pricing its own verified stock. Site C, priced close to Site A but tied to a different lot number entirely, is the one making an independent claim that can actually be checked against its own paperwork.
Cross-Checking Contact and Ordering Details
Beyond photos and documents, duplicate listings often share less visible infrastructure: the same return-policy wording, the same order-tracking portal, or a support email on a domain that doesn’t match the storefront’s own name. None of these prove a listing is copied, but a cluster of them — identical photos, identical COA, and a support contact hosted under a third domain — points toward a single operation running several front-end storefronts rather than several independently sourced sellers. Reading the ordering and contact sections side by side across listings a buyer is comparing is a quick way to see whether that pattern holds.
What Independent Documentation Looks Like Instead
A listing that has actually verified its own stock will usually show small, specific differences from its competitors even when selling a similar compound: its own product photography, a COA with a lot number that doesn’t appear elsewhere, and vial-mass and pricing figures that reconcile on their own terms rather than mirroring another page’s numbers with a markup applied. None of this requires special tools — a reverse image search, a text search on a lot number, and a calculator are enough to check most of it directly from the listing pages themselves.
The compound’s regulatory history is a useful anchor for judging what real documentation should look like: tesamorelin’s FDA approval for HIV-associated lipodystrophy came with a specific formulation and manufacturing record, and more recent literature reviewing therapeutic peptides in metabolic and endocrine research continues to describe GHRH analogs like tesamorelin with the same level of batch and formulation specificity. A retail listing that can’t offer comparable specificity about its own inventory is falling short of a standard that already exists in the published record for this compound.
Summary
Spotting duplicate tesamorelin listings across different supplier websites is mostly a matter of comparing what’s actually on the page against what shows up on other pages: identical product photos, identical COA images and lot numbers, matching text errors, and price-per-milligram figures that don’t reconcile with a shared batch claim. None of these checks require special access — a reverse image search, a text search, and basic division cover most of it. A listing that shows its own photography, its own lot number, and pricing that holds up under that arithmetic is making an independent claim a reader can actually evaluate.